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Abstract
Telehealthcare is a rapidly growing field of clinical activity and technical development. These new technologies have
caught the attention of clinicians and policy makers because they seem to offer more rapid access to specialist care, and
the potential to solve structural problems around inequalities of service provision and distribution. However, as a field
of clinical practice, telehealthcare has consistently been criticised because of the poor quality of the clinical and
technical evidence that its proponents have marshalled. The problem of ‘evidence’ is not a local one. In this paper, we
undertake two tasks: first, we critically contrast the normative expectations of the wider field of Health Technology
Assessment (HTA) with those configured within debates about Telehealthcare Evaluation; and second, we critically
review models that provide structures within which the production of evidence about telehealthcare can take place. Our
analysis focuses on the political projects configured within a literature aimed at stabilising evaluative knowledge
production about telehealthcare in the face of substantial political and methodological problems.
# 2002 Elsevier Science Ireland Ltd. All rights reserved.
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1. Introduction
Telehealthcare is a rapidly growing field of
clinical activity and technical development. Emer-
ging information and communications technolo-
gies are increasingly being applied to interaction
between professional and patient, and to the
mediation of clinical data across time and space.
These new technologies (described in Fig. 1) have
caught the attention of clinicians and policy
makers because they seem to offer more rapid
access to specialist care, and the potential to solve
structural problems around inequalities of service
provision and distribution. In the UK, the govern-
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ment is clear that these new technologies should be
configured as a part of a modernising National
Health Service.
Opportunities in the field of telemedicine will be
seized to remove distance from healthcare, to
improve the quality of that care, and to help
deliver new and integrated services [1].
However, optimistic policy discourse about
telemedicine might be, in practice these new
technologies seem to have not ‘diffused’ into
practice, and penetrated service provision. This
situation is reflected in the retarded development
of telehealthcare internationally. Similar con-
straints seem to apply not just in the UK [2] but
also in the US [3] and France [4]. There are a
Fig. 1. Modes of telehealthcare.
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number of reasons for this. First, there are macro-
level structural problems around the capitalisation
of new technology projects [5]; in the US there are
problems of reimbursement and licensure that
affect clinicians [3]; and there are key difficulties
in reconfiguring clinical practice through such
technologies [6]. Underpinning these difficulties,
however, is a more serious problem: as a field of
clinical practice, telehealthcare has consistently
been criticised because of the poor quality of the
clinical and technical evidence that its proponents
have marshalled [2,7].
The problem of ‘evidence’ is not a local one. It is
represented internationally, for across the ad-
vanced economies the production of an ‘evi-
dence-base’ for practice has become a major
focus of investment and endeavour in health
policy, spawning a major research enterprise under
the ambit of health technology assessment (HTA)
[8/10]. In this context, proponents of telehealth-
care have sought ways to integrate their own
technologies of evaluation with the wider norma-
tive expectation of HTA.
In this paper, we undertake two tasks: first, we
critically contrast the normative expectations of
HTA with those that circulate within the field of
Telehealthcare Evaluation; and second, we criti-
cally review the literature that configures models
of structures within which the production of
evidence about telehealthcare can take place. Our
interest is in the collision between two kinds of
political project around conventional forms of
knowledge production: one, HTA inherently con-
servative and methodologically parsimonious; the
other around Telehealthcare Evaluation, repre-
sented by an expansionist and evangelical body
of literature aimed at stabilising and normalising a
field to techniques and technologies of clinical
practice in the face of substantial political and
methodological problems. The analysis that we
present, therefore, is not a critique that calls
Telehealthcare Evaluation (THE) to account
against the methodological precepts of HTA, but
rather an account of the political imperatives that
proponents of telehealthcare are working to ad-
dress in the face of unstable knowledge and
practice.
2. The normative expectations of HTA
We have already observed that ‘evidence’ is a
problem for proponents of telehealthcare. Indeed,
a consistent criticism of the existing evaluative
literature in the field has been that it is organised
around studies that are often methodologically
unsound, and which, thus, provide little in the way
of solid evidence for practice [2,7]. This position
has been adopted by key protagonists of tele-
healthcare [11], who have suggested that an
explanation for the paucity of ‘high quality
studies’ is that it is an emergent technology that
has not yet achieved sufficient penetration of
health care systems to attract the attention of
major funding agencies [5].
Even so, the production of knowledge about
telehealthcare is contentious. The authors of much
of the literature around methodology in Tele-
healthcare Evaluation have adopted external defi-
nitions of ‘high quality’ research and evaluation
techniques that draw on the substantial literature
around HTA, but they also recognise that these
bring significant problems in their wake. For
example, in an account that is typical of the genre
Holle and Zahlmann assert that:
It has to be clear that the evaluation of
telemedical services requires no unique and
special method of its own. Telemedicine is
nearly as heterogeneous as conventional medi-
cal practice, and the evaluation methods of
telemedicine are in the first place those needed
for studying conventional diagnostic or ther-
apeutic procedures. (. . .) Rapid technological
development makes long-term studies irrelevant
because the equipment is outdated by the time
the results are published. (. . .) Telemedicine
often requires a distribution of new technology
to former non-users and, therefore, depends
greatly on the acceptability of this new equip-
ment. (. . .) Many telemedicine applications are
confined to specific geographical reasons with a
sparse population and, thus, large sample sizes
that are needed for statistical reasons are hard
to obtain. Telemedical applications often in-
volve many different institutions using different
systems and technologies which complicate the
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necessary technical standardisation [12] p. 84/
5.
For these authors, Telehealthcare Evaluation
has no special conditions that set it apart from
other fields of research on medical care, except of
course that it does. They set out structural
constraints (e.g. the integration of the hardware
into the service) and methodological problems
(e.g. study length and sample size) that explain
why Telehealthcare Evaluation does not fit the
HTA mold. This represents more than a metho-
dological problem, since successful evaluation is
the means by which telehealthcare will come to be
seen as a stable mode of clinical practice and
service delivery, and is the key to adoption. If
HTA were only a matter of methods, it is
conceivable that an alternate body of methods
could be found that would provide an acceptable
knowledge base. Formative process evaluation
using qualitative techniques would, for example,
provide a completely different but equally robust,
basis for evidence about telehealthcare. But HTA
is not just a matter of method, and is surely more
appropriately characterised as a political move-
ment, one that fits well with the increasingly
technocratic and managerial thrust of government
in the advanced economies*/where the contests
about health care provision and management are
increasingly articulated to the production of
evidence. Within its own terrain, practitioners of
HTA characterise their aims as:
To provide advice to ensure that those new
technologies that provide improvements to
health-care outcomes by more efficient and
effective methods are fostered, while those
technologies that do not add value to either
efficiency of health status are not promoted [13]
(p. 139).
So the problems outlined by Holle and Zahl-
mann, above, reflect the sense in which methodo-
logical problems represent political problems
about the stabilisation of both technologies that
mediate new forms of clinical practice, and the
techniques through which these are to be con-
ducted. We can find the basis of their dilemma in
the central characteristics of HTA as a field of
disciplinary practice.
a) HTA is a field of knowledge production that is
policy-purposive: it arises out of responses to
rising expenditure on health care, and is an
attempt to deploy evidence that meets well
defined and agreed standards of quality*/to
inform the regulation and organisation of
health care provision according to formal
and rational principles [13/15].
b) HTA is characterised by the concentration of
formal, standardised and synthetic quantita-
tive methods. These lead to ‘reliable’ discov-
eries on the basis of ‘gold standard’
randomised controlled trials [16,17] in which
data are seen as constituted through politically
neutral quanta and interpreted by statistical
tests, rather than social or political judgements
[18]. Knowledge can only be accumulated and
extended here, through the application of
systematic review or meta-analysis as second-
ary research strategies [13], again constituted
through explicit and agreed procedures that
focus on apparently asocial quantities.
c) HTA defines technology broadly. Within the
bounds of HTA, almost any kind of health
care related practice; decision making or
costing structure; treatment modality; or pat-
tern of organisation and service delivery, is
open to interrogation about their safety;
efficacy; clinical effectiveness; impact on qual-
ity of life, and social appropriateness [19].
Technique, technology and variant levels of
organisational practice are all open to its
methodological gaze.
d) HTA is multi-disciplinary. As a technical field
of practice, and as a technocratic movement,
HTA co-opts and harnesses a range of dis-
ciplines [9]. As HTA focuses its attention on
the methods by which knowledge is produced
and assessed, and projects this through a
rhetoric of neutral facticity, it is unaffected
by disciplinary boundaries*/but through lay-
ing claim to method as its strength, theoretical
and philosophical positions are subordinated
to technique [20].
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e) HTA is collaborative and international. The
apparent neutrality and apolitical status of
HTA methodology forms the basis for its
strategic expansion*/large scale enterprises
like the Cochrane Collaboration operate
around shared and agreed notions of how
evidence should be constructed, synthesised
and applied. Their relevance is assumed to
extend beyond local contexts.
The apparently strict formality of knowledge
production practices within HTA relates to its
central concern with quantitative studies that are
open to statistical interpretation. This does not
mean that its practitioners are not concerned with
other methodological approaches, or with other
perspectives on the objects of their gaze. Qualita-
tive methods and ethical questions do figure in
their interests*/but these are difficult to appre-
hend and synthesise within the constraints of
standardisation with which they are also con-
cerned. Qualitative studies pose special problems
here [21], since they resist standardisation and
their data defy the kinds of neutral interpretation
that are supposedly present in quantitative studies.
HTA approaches the production of evidence
about health care in ways that are attractive to
policy makers for the same reasons that telehealth-
care systems are: they offer a politically neutral
technical fix for structural problems. Crucially,
they focus on safely improving efficiency, and
reducing costs. But they are also subject to a wide
ranging critique that focuses on the social con-
struction of the categories and practices through
which their formal methods are applied
[9,10,22,23]. Central to this critique is the con-
tested tension between (quantitative) cost and
(qualitative) values:
[HTA] may appear to be value neutral because
the results are expressed in quantitative, mone-
tary terms rather than in qualitative values.
However, (. . .) important ethical values may lie
behind the goals of any intervention: presuppo-
sitions about normalcy and the proper response
to disease give the determination of effective-
ness a decidedly value laden cast [23] (p. 556).
For the purposes of our account HTA is
important because it defines a field of practice
that is dominated by rules-based knowledge pro-
duction, and acts as a point of departure for
criteria of adequacy in knowledge about health
care practice that permit the success or failure of
technologies to be measured. Here, the general
conditions established within its domain are read-
ily transferable and widely agreed. In stressing the
value of biomedical research procedures like the
randomised controlled trial, it emulates the kinds
of scientific enterprise that have become the agreed
underpinnings of biomedicine’s strategic expan-
sion. In short, HTA has been established through
a community of practice that defines what accep-
table facts about a technology are, and how they
should be constructed. These definitions of facts
become organised into research and evaluation
procedures [24] and so become, as we have seen in
Holle and Zahlmann’s [12] dilemma, a real pro-
blem for telehealthcare evaluators.
3. Telehealthcare evaluation models
The position that we have adopted, thus, far is
that the highly stable, widely agreed, and formally
structured precepts of HTAs are a practical, and a
disciplinary, problem for Telehealthcare Evalua-
tion because of the structural, technical, and
methodological constraints that are experienced
by telehealthcare practitioners. Underpinning this
is the perceived instability of telehealthcare, and
we have already outlined some of the difficulties
that its proponents encounter in attempting to
launch it as a means of delivering services about
which there is reliable knowledge [2]. The produc-
tion of such knowledge is, therefore, a priority for
clinicians and others who wish to define and
develop this clinical field of practice.
Recognition within the telehealthcare commu-
nity that the evidence that it marshals has been
inadequate and unconvincing runs through its own
specialist literature. In part, this has been because
what*/in the mid-1990s*/were conceived of as
the ‘first wave’ [25] of Telehealthcare Evaluations
were focused on hardware rather than clinical
practice. This is a common point of departure for
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commentaries on telehealthcare assessment, for
example:
It is evident that the scientific and commercial
developers of the new technologies have con-
fidence in their products. However, a more
critical approach is required from evaluators
of the systems. This critical attitude is starting
to be displayed (. . .). A change seems to have
taken place in problem description. Originally
evaluators focused exclusively on the technolo-
gical functioning of the information systems.
Now they have begun to pay attention to the
chances of [it] being integrated into the envir-
onment and being adopted. [26] (p. 157).
But at the end of the 1990s, Hailey et al. [27]
were forced to observe that ‘there has so far been
little systematic monitoring of the effectiveness
and efficiency of telemedicine’ (p.169); while
Pelletier-Fleury [4] and colleagues noted that ‘little
or no evaluations have been conducted within a
decision-making perspective’ (p. 181). Added to
this have been systematic reviews of patient
satisfaction studies [7] and economic evaluations
[28] which have been highly critical of the conduct
of Telehealthcare Evaluation as a field of practice.
Problems identified include small sample sizes,
short duration of projects, and lack of standardi-
sation in data collection [12,29/31]. Indeed, de-
spite high levels of investment in demonstration
projects and systems development, there is little
solid evidence about the utility and efficacy of
telehealthcare systems that stands up to normative
criteria applied elsewhere in health services re-
search. The political thrust of this kind of work is
evident in the assertion that:
For the hard pressed administrator, the reality
is not so much concern regarding methodolo-
gical rigour of an assessment, but whether key
issues such as those identified in this paper will
be addressed at all. (. . .) If these various issues
are not addressed, health care consumers,
administrators and professionals will run the
risk of having to use telemedicine systems that
are not responsive to their needs or which do
not provide cost effective services [27] (p. 169:
italics ours).
More to the point, consumers, administrators
and professionals might not wish to use them at
all. While the products of evaluation and assess-
ment in telehealthcare have been widely criticised
from within, and from outside, of the community
of practice [32] in which telehealthcare is situated,
over the past decade a body of specialist technical
literature has emerged, which presents methods
and techniques through which the assessment and
evaluation of telehealthcare might be accom-
plished in ways that satisfy external observers,
but that also frames knowledge production and
stabilisation as a political project.
The emergence of a body of normative literature
about Telehealthcare Evaluation is interesting
because it seeks not only to set out ‘models’ of
evaluation that meet the demands of external
adjudication, but because it also seems to work
towards giving Telehealthcare Evaluation a con-
ceptual structure of its own. We outline some of
these approaches below, and offer a detailed
description of the central features of this literature
in Fig. 2. The constituent features of Telehealth-
care Evaluation seem much less solid than those of
HTA:
i) Prescriptive models may set out the most basic
considerations for evaluators to follow. For
example, Bashshur [25] identifies three condi-
tions which must be met before commencing a
Telehealthcare Evaluation: appropriate envir-
onments and specific health care needs that
can be expected to be met by the system must
be identified; the informational requirements
necessary for practicing remote medicine must
be established; and the technical capabilities of
the system must be exploited to full potential.
These ‘preconditions’ however, appear to
relate more to the telehealthcare system itself
than to the evaluation of it. Similarly, Yellow-
lees [33] sets out six ‘fundamental questions’ of
who, why, what, where, when and how. These
questions relate to pre-assessment of the
objectives of the service, and of the means of
evaluating those objectives.
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ii) Prescriptive models may identify specific is-
sues that need to be accommodated within an
evaluation. General frameworks for Tele-
healthcare Evaluation sometimes attempt to
define ‘levels’ of activity [34,35], and typically
include distinctions between dimensions such
as safety [25,30], medical effectiveness
[25,30,31], cost-effectiveness [25,27,30,31],
Fig. 2. Telehealthcare Evaluation models.
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and acceptability [25,31]. Although similar in
content, the models do vary to some extent in
how they describe the structure of evaluation.
Bashshur [25] divides Telehealthcare Evalua-
tion into two types: biomedical, and health
services. The biomedical approach is con-
Fig. 2 (Continued)
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cerned with clinical effectiveness and safety,
and usually involves performance studies [27]
and clinical trial methodology. An alternative
approach is to describe the kinds of data that
need to be collected. For example, Perednia
[30] identifies aspects such as safety and
effectiveness that can be evaluated using three
types of indicators that relate to inputs
(resources allocated to telehealthcare), pro-
cesses (measures that describe activity), and
outcomes (which relate to effects on health).
In a similar fashion, Hailey and colleagues [27]
focus on: specification; performance measures;
outcomes; summary measures; and other con-
siderations (such as legal issues and accept-
ability).
iii) Prescriptive models may identify stages of
activity in evaluation in relation to the devel-
opment of the technology itself [12,36]. In
Holle and Zahlmann’s model, Telehealthcare
Evaluation is described as a linear progression
from technical evaluation, to clinical outcomes
and cost-effectiveness in the final stage. Spe-
cifically, evaluation evolves across the follow-
ing consecutive stages of: a technical pilot
study; feasibility study; controlled effective-
ness study; and cost-effectiveness study. De-
Chant and colleagues 36 propose a similar
model but exclude cost-effectiveness. These
models [36] share the assumption that evalua-
tion begins with laboratory testing of the
technology, before moving stepwise towards
full clinical practice.
iv) The models may move explicitly towards the
normative structure of HTA. Models of Tele-
healthcare Evaluation that have a more lim-
ited focus include those designed specifically
for the assessment of medical effectiveness
Fig. 3. Contrasting characteristics of HTA and Telehealthcare Evaluation literature.
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Fig. 3 (Continued)
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[37], cost effectiveness [38,39], and psychoso-
cial aspects [40]. In Stamm and Perednia’s [40]
model, attention is drawn to ‘human consid-
erations’ of telehealthcare, under five general
categories: technical training; informatics sup-
port; remote consultation and supervision;
categories of services provided, and mainte-
nance of service providers. Effects of tele-
healthcare systems on these more ‘human’
aspects of health care provision are frequently
neglected in more general models of Tele-
healthcare Evaluation.
Telehealthcare Evaluation models constitute a
baroque structure for the production of knowl-
edge, and they seem to bracket off the field from
other areas of research in medicine or HTA. The
focus on ‘models’ of evaluation is an unusual one,
and we might partially account for it by reference
to the impetus to integrate technology into clinical
practice. But there is another way to understand
this literature too. This is to see these models not
as attempts at methodological innovations but
rather as an attempt to map the components of
telehealthcare, and to define those processual and
structural points about which calculations of
efficacy and utility need to be made. In this context
the ‘models’ of evaluation that we have discussed
above can be seen to be about defining the points
of contact between Telehealthcare Evaluation and
the kinds of knowledge normatively constructed in
the wider disciplinary field of HTA. This is a
position adopted explicitly by Hailey et al. [27],
who are concerned to directly connect the business
of Telehealthcare Evaluation with wider con-
structs of HTA. It is also the case that this is a
genuinely instructional literature, which addresses
the problems of practicing clinicians who are not
always experienced researchers but who wish to
develop a service and demonstrate its effectiveness.
Interestingly, while in HTA the interests of pa-
tients are constructed in quite complex ways (as
consumers, and as potential decision-makers, for
example), within Telehealthcare Evaluation they
are represented through patient ‘satisfaction’ stu-
dies that often have little to say about users’ views
[7].
The literature around methods and models in
Telehealthcare Evaluation seems, then, to set it*/
and its practitioners*/apart from the wider litera-
ture on HTA. Recognition of the political im-
perative to produce high quality quantitative data,
is systemically undercut by the problematic status
of the technology and techniques implicated in
telehealthcare, and the organisational structures in
which these are located are also assumed to be
confounding factors.
4. Telehealthcare evaluation and the search for
stable knowledge
So far, we have discussed HTA and Telehealth-
care Evaluation in terms of their normative
judgements about the success or failure of a health
care practice. We have also observed that models
of Telehealthcare Evaluation represent the impor-
tant political project of normalising and stabilising
knowledge about this emergent technology for
clinical practice. In Fig. 3 we draw a contrast
between HTA as a general field, and Telehealth-
care evaluation as one of its sub-fields. Both are
Fig. 3 (Continued)
T. Williams et al. / Health Policy 64 (2003) 39/54 51
part of a major enterprise, organised around the
notion that:
The outcomes of health care have not received
sufficient attention, that physicians know too
little about what produces desired health ef-
fects, and that outcomes research will remedy
this situation, thereby, containing costs and
ensuring quality [8] p. 28.
The policy implications of this search for
certainty are considerable, precisely because the
problem of effectiveness is increasingly related to
the problems of costs, and, therefore, intervenes in
the relationship between clinician and patient [41].
Not surprisingly, therefore, recent years have seen
vigorous debates about how best to produce
evaluative ‘facts’ about health care technologies
and treatment modalities. For the most part, these
debates have taken as their central focus metho-
dological questions*/about technique*/and have
treated the business of evaluation as an asocial and
acontextual set of practices that have self-evident
effects. There has been much less empirical inquiry
into the social and contextual features of evalua-
tion practices, and the dynamic political processes
that run through them. What this means is that
while there are sometimes vigorous debates about
which evaluative technique is best, the purposes to
which they are put remain apparently self-evident.
In this context, the evaluation of telehealthcare
means a good deal more than the production of
neutral ‘facts’: it offers the potential for stabilising
the technology, and normalising its use in clinical
practice, through convincing a wider professional
audience of the value of the technology. However,
as one of the leading proponents of telehealthcare
practice observes, this is not a process that can be
taken for granted:
Strangely enough, those who toiled earlier to
convince sceptical health policy makers and
reluctant providers of the potential merit of
telemedicine systems have been vindicated, not
so much by the virtue of their eloquence, sound
logic, or positive scientific findings, but rather
by the sheer persistence of the serious problems
in health care whose amelioration, if not
resolution, still promises to be amenable, at
least in theory, to telemedicine [25] p. 20.
The appeal here is not to the kinds of certainty
and evidence to be found elsewhere in the technol-
ogy evaluation literature, but rather to the ‘theo-
retical’ promise that telehealthcare offers in the
face of intractable problems. For proponents of
these technologies to shift beyond this ‘theoretical’
knowledge about promise, and to begin to stabilise
their technology and its linked clinical practices,
facts, about success and failure need to be
constructed in quite specific ways, that meet the
normative demands of a range of agencies. It is
important also to note that evaluations are them-
selves a kind of technology (where knowledge and
practice are embedded in a research protocol and
its procedures). For the most part, evaluations
within the broader frame of HTA typically are
understood to be stable, and rely on well estab-
lished and validated forms of measurements
around which there are formed strong networks
of agreement [42]. A crucial problem for tele-
healthcare evaluators has, therefore, been how to
enrol the techniques of evaluation practice into the
production of stable facts about the ‘hard’ tech-
nology of telehealthcare. This understanding, that
the conventional systems of biomedical knowledge
production (for e.g. the randomised controlled
trial and the case controlled study) are necessary
for telehealthcare to become a credible form of
clinical practice, is countered by concerns about
characteristic ‘problems’ of new technology eva-
luation that undermine the impulse towards stable
and agreed patterns of knowledge building. Holle
and Zahlmann, whose work we discussed earlier,
themselves exemplify this contradictory position
[12].
Recognition of methodological inadequacy
within the domain of telehealthcare practice is
widespread. This is explained by critics within the
domain of telehealthcare research who point to an
overemphasis on evaluating hardware, and to an
uncritical assumption that telehealthcare systems
are beneficial to patients [26]. As evidenced in this
paper, a key result of this recognition of metho-
dological inadequacy has been a concerted pro-
gramme of writing and publication by key
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proponents of telehealthcare, which sets out pre-
scriptive models of technical adequacy for tele-
healthcare systems design, implementation and
evaluation. This literature is not simply educa-
tional or exhortative. It is also about integrating
Telehealthcare Evaluation into the wider domain
of HTA, working against a set of stable normative
criteria to convince key actors in other commu-
nities of practice.
Our point here is that the stability of telehealth-
care as a mode of clinical practice that might
become become normalised into service provision
work depends upon the construction of agreed
knowledge, formed around shared rules, about its
effectiveness. We have observed that this is typi-
cally conceived of as taking the form of quantita-
tive evidence, but have also noted that the focus on
quantitative evidence that has been manufactured
through statistical procedures needs to be under-
stood in its wider social context. The key point
here is that quantitative assessments of efficacy
and utility are formed and disciplined through
qualitative judgements that are inherently politi-
cal. Importantly, these processes are marked by
significant contests and disagreements not only
over the kinds of evidence that are persuasive of
effectiveness, but also by territorial disputes about
whose knowledge is authoritative in constructing
the focus of the quantitative enterprise, and which
stem from the functional specialisation of different
participants in the evaluative process. Here, spe-
cific communities of practice [32] define and form
their own structures of reliable knowledge. The
emergent nature of telehealthcare systems, and
their uncertain impact on organisational and
professional structures [43], mean that evaluation
is not self-evident, but that it demands mapping in
ways that construct an alternative to the conven-
tional model of biomedical research.
Acknowledgements
The study from which this paper is drawn is
funded by the UK Department of Health (Project
ICT/032), and this support is gratefully acknowl-
edged. The paper presents the views of the authors
and not of the UK Department of Health. We also
thank Mrs. Denise Mukadam for her adminis-
trative support of the study.
References
[1] National Health Service Executive. Information for health:
an information strategy for the modern NHS 1998/2001.
London: National Health Service Executive, 1998.
[2] May C, Mort M, Mair F, Ellis NT, Gask L. Evaluation of
new technologies in health care systems: what’s the
context. Health Informatics Journal 2000;6:67/70.
[3] Bashshur RL. Critical issues in telemedicine. Telemedicine
Journal 1997;3:113/26.
[4] Pelletier-Fleury N, Lanoe JL, Philippe C, Gagnadoux F,
Rakotonanahary D, Fleury B. Economic studies and
‘technical’ evaluation of telemedicine: the case of telemo-
nitored polysomnography. Health Policy 1999;49:179/94.
[5] May C, Mort M, Mair F, Williams T. Factors affecting the
adoption of telehealthcare in the United Kingdom: the
policy context and the problem of evidence. Health
Informatics Journal 2001;7:131/4.
[6] May C, Gask L, Atkinson T, Ellis NT, Mair F, Esmail A.
Resisting and promoting new technologies in clinical
practice: the case of telepsychiatry. Social Science and
Medicine 2001;52:1889/901.
[7] Mair F, Whitten P. Systematic review of studies of patient
satisfaction with telemedicine. British Medical Journal
2000;320:1517/20.
[8] Tanenbaum SJ. Knowing and acting in medical research:
the epistemological politics of outcomes research. Journal
of Health Politics, Policy and Law 1994;19:27/44.
[9] Faulkner A. Strange bedfellows in the laboratory of the
NHS. In: Elston MA, editor. The sociology of medical
science and technology. Oxford: Blackwell, 1997:183/207.
[10] Lehoux P, Blume S. Technology assessment and the
sociopolitics of health technologies. Journal of Health
Politics, Policy and Law 2000;25:1083/120.
[11] Wootton R. Telemedicine-a cautious welcome. British
Medical Journal 1996;313:13375.
[12] Holle R, Zahlmann G. Evaluation of telemedical services.
IEEE Transactions on Communications 1999;3:83/9.
[13] Kearney B. Health technology assessment. Journal of
Quality in Clinical Practice 1996;16:131/43.
[14] Woolf SH, Henshall C. Health technology assessment in
the United Kingdom. International Journal of Technology
Assessment in Health Care 2000;16:591/625.
[15] Adang EM, Ament A, Dirksen CD. Medical technology
assessment and the role of economic evaluation in health
care. Journal of Evaluation in Clinical Practice
1996;2:287/94.
[16] Goodman CS, Ahn R. Methodological approaches of
health technology assessment. International Journal of
Medical Informatics 1999;56:97/105.
T. Williams et al. / Health Policy 64 (2003) 39/54 53
[17] Abrams HL, Hessel S. Health technology assessment:
problems and challenges. American Journal of Roentgen-
olology 1987;149:1127/32.
[18] Oakley A. Experiments in knowing: gender and method in
the social sciences. Cambridge: Polity, 2000.
[19] Menon D, Marshall D. The internationalization of health
technology assessment. International Journal of Technol-
ogy Assessment in Health Care 1996;12:45/51.
[20] Pilgrim D, May C. Social scientists and the British
National Health Service. Social Science and Health
1998;4:42/54.
[21] Murphy E, Dingwall R, Greatbatch D, Parker S, Watson
P. Qualitative research methods in health technology
assessment: a review of the literature, Health Technology
Assessment 1998; 2: iii-274.
[22] Battista RN, Lance JM, Lehoux P, Regnier G. Health
technology assessment and the regulation of medical
devices and procedures in Quebec. Synergy, collusion, or
collision. International Journal of Technology Assessment
in Health Care 1999;15:593/601.
[23] Heitman E. Ethical issues in technology assessment.
Conceptual categories and procedural considerations.
International Journal of Technology Assessment in Health
Care 1998;14:544/66.
[24] May C, Ellis NT. When protocols fail: technical evalua-
tion, biomedical knowledge, and the social production of
‘facts’ about a telemedicine clinic. Social Science and
Medicine 2001;53:989/1002.
[25] Bashshur R. On the definition and evaluation of teleme-
dicine. Telemed Journal 1995;1:19/30.
[26] Burghgraeve P, De Maeseneer J. Improved methods for
assessing information technology in primary health care
and an example from telemedicine. Journal of Telemedi-
cine and Telecare 1995;1:157/64.
[27] Hailey D, Jacobs P, Simpson J, Doze S. An assessment
framework for telemedicine applications. Journal of Tele-
medicine and Telecare 1999;5:162/70.
[28] Whitten P, Mair F, Haycox A, May C, Williams T,
Helmich S. Systematic review of cost effectiveness studies
of telehealthcare interventions. British Medical Journal
2002;324:1434/7.
[29] Grigsby J, Kaehny MM, Sandberg EJ, Schlenker RE,
Shaughnessy PW. Effects and effectiveness of telemedicine.
Health Care Financing Review 1995;17:115/31.
[30] Perednia D. Telemedicine system evaluation and a colla-
borative model for multi-centred research. Journal of
Medical Systems 1995;19:287/94.
[31] Puskin D, Brink L, Mintzer C, Wasem C. Letter to the
editor. Joint federal initiative for creating a telemedicine
evaluation framework. Telemedicine Journal 1995;1:395/
9.
[32] Wenger E. Communities of practice: learning, meaning
and identity. Cambridge: Cambridge University Press,
1998.
[33] Yellowlees P. Practical evaluation of telemedicine systems
in the real world. Abstracts: TeleMed 1997;97:90/3.
[34] Filiberti D, Wallace J, Koteeswaran R, Neft D. A
telemedicine transaction model. Telemedicine Journal
1995;1:237/47.
[35] Rockoff ML, Bennett AM. The ‘patient trajectory’: a
modeling tool for planning and evaluating rural telemedi-
cine systems. In: Elton M, Lucas W, Conrath D, editors.
Evaluating new telecommunications services. NewYork:
Plenum Press, 1978:79/106.
[36] DeChant H, Tohme W, Mun S, Hayes W, Schulman K.
Health systems evaluation of telemedicine: a staged
approach. Telemedicine Journal 1996;2:303/12.
[37] Grigsby J, Schlenker R, Kaehny M, Shaughnessy P,
Sandberg E. Analytic framework for evaluation of tele-
medicine. Telemedicine Journal 1995;1:31/9.
[38] Sisk JA, Sanders JH. A proposed framework for economic
evaluation of telemedicine. Telemedicine Journal
1998;4:31/7.
[39] McIntosh E, Cairns J. A framework for the economic
evaluation of telemedicine. Journal of Telemedicine and
Telecare 1997;3:132/9.
[40] Stamm H, Perednia D. Evaluating the psychosocial aspects
of telemedicine and telehealth systems. Professional Psy-
chology Research and Practice 2000;31:184/9.
[41] Harrison S. Clinical autonomy and health policy: past and
futures. In: Exworthy M, Halford S, editors. Professionals
and the new managerialism in the public sector. Bucking-
ham: Open University Press, 1999:50/64.
[42] Bartley M, Davey Smith G, Blane D. Vital comparisons:
the social construction of mortality measurement. In:
Elston M-A, editor. The sociology of medical science and
technology. Oxford: Blackwell, 1997:127/51.
[43] Rigby M. The management and policy challenges of the
globalisation effect of informatics and telemedicine. Health
Policy 1999;46:97/103.
[44] Huston JL, Burton DC. Patient satisfaction with multi-
specialty interactive teleconsultations. Journal of Teleme-
dicine and Telecare 1997;3:205/8.
T. Williams et al. / Health Policy 64 (2003) 39/5454
